medigraphic.com
ISSN 0016-3813 (Print)

2009, Number 1

<< Back Next >>

Gac Med Mex 2009; 145 (1)

Factores pronósticos y sobrevida de pacientes pediátricos con ependimomas

López-Aguilar E, Sepúlveda-Vildósola AC, Betanzos-Cabrera Y, Gascón-Lastiri G, Ortiz-Suárez L, Rivera-Márquez H, Cerecedo-Díaz F, Wanzke-Del Ángel V, Cruz-Yáñez H, Ramírez-Reyes G, Arenas-Arandad D, Siordia-Reyes G

Language: Spanish
References: 34
Page: 7-14
PDF size: 101.68 Kb.


ABSTRACT

Background: Ependymomas constitute the third most common intracranial tumors in children. Risk factors include age, location, extent of surgical excision, and radiation therapy. Recently, chromosomal imbalances have been described. Objective: Determine global survival of patients with ependymomas according to different prognostic factors. Methods: We reviewed the medical charts of every pediatric patient with ependymoma from 1996 to 2005. Genomic imbalances were determined using comparative genomic hybridization (CGH). Survival was calculated using the Kaplan and Meier method. We used the Log Rank test for each risk factor. Death risk was calculated by odds ratio (OR). Results: We included 24 patients. Global survival was 58.04%. The presence of chromosomal imbalances, particularly in chromosome 21, significantly affected survival. Being under 5 years of age, anaplastic histology, chemotherapy other than ICE (ifosfamidacarboplatin- etoposide) and partial resection increased the risk of death. Conclusions: Known risk factors were confirmed in our study, including chromosomal imbalances. We describe a new chromosomal imbalance in chromosome 21 among 30% of study participants.


REFERENCES

  1. Sepúlveda-Vildósola AC, Rivera-Luna R, Medina A, Aguilar M, López-Aguilar E. Epidemiology of central nervous system tumors in children. Report of the Mexican Brain Tumor Study Group. Pediatr Blood Cancer 2006;47:454(PE 003).

  2. Coulon RA, Till K. Intracranial ependimomas in children. Child Brain 1977;3:154-168.

  3. Juárez-Ocaña S, González-Miranda G, Mejía-Aranguré JM, Rendón-Macías ME, Martínez-García MC, Fajardo-Gutiérrez A. Frequency of cancer in children residing in Mexico City and treated in the hospitals of the Instituto Mexicano del Seguro Social (1996-2001). BMC Cancer 2004;4:50.

  4. Fajardo-Gutiérrez A, Juárez-Ocaña S, González-Miranda G, Palma-Padilla V, Carreón-Cruz R, Mejía-Aranguré JM. General and specific incidence of cancer among children affiliated to the Mexican Institute of Social Security. Rev Med Inst Mex Seguro Soc 2007;45:579-592.

  5. Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neurol Clin 2003;21:897-913.

  6. Pollack IF, Gerszten PC, Martínez AJ, Lo, Kim-Hung MS, Shultz BB,Albright AL, et al. Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 1995;37:655-667.

  7. Hanbali F, Fourney D, Marmor E, Suki D, Rhines L, Weinberg J, et al.Spinal cord ependymoma: Radical surgical resection and outcome. Neurosurgery 2002;51:1162-1174.

  8. Perilongo G, Massimino M, Sotti G, Belfontali T, Masiero L, Rigobello L, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymomas: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 1997;29:79-85.

  9. Rivera-Luna R, Medina-Sanson A, Leal-Leal C, Pantoja-Guillén F, Zapata-Tarrés M, Cárdenas-Cardós R, et al. Brain tumors in children under 1 year of age: Emphasis on the relationship of prognostic factors. Child Nerv Syst 2003;19:311-314.

  10. Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg 2000;93:605-613.

  11. Shu HK, Sall WF, Maity A, Tochner AZ, Janss AJ, Belasco JB, et al.Childhood intracranial ependymomas: Twenty-year experience from a single institution. Cancer 2007;110:432-441.

  12. Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, Rushing EJ. The prognostic value of histological grading of posterior fossa ependymomas in children: A Children’s Oncology Group Study and a review of prognostic factors. Mod Pathol 2008;21:165-177.

  13. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 2002;161:2133-2141.

  14. Zamecnik J, Snuderl M, Eckschlager T, Chanova M, Hladikova M, Tichy M,et al. Pediatric intracranial ependymomas: Prognostic relevance of histological, immunohistochemical and flow cytometric factors. Mod Pathol 2003;16:980-991.

  15. Armas-Pineda C, Arenas-Huertero F, Pérezpeñia-Diazconti M, Chico-Ponce de León F, Sosa-Sáinz G, Lezama P. Expression of PCAF, p300 and Gcn5 and more highly acetylated histone H4 in pediatric tumors. J Exp Clin Cancer Res 2007;26:269-276.

  16. Nishimori H, Nishikawa R, Fujimaki T, Nakagomi T, Matsutani M, Huang HJ, et al. Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors. J Neurooncol 2000;46:17-22.

  17. Lo S, Abdulrahman R, DesRosiers P, Fakiris A, Witt T, Worth R, et al. The role of gamma knife radiosurgery in the management of unresectable gross disease or gross residual disease after surgery in ependymoma. J Neuroncol 2006;79:51-56.

  18. Grill J, Pascal C, Chantal K. Childhood ependymomas: A systematic review of treatment options and strategies. Paediatr Drugs 2003;5:533-543.

  19. Grundy RG, Wilne SA, Weston CL, Robinson K, Lashford LS, Ironside J,et al. Primary postoperative chemotherapy without radiotherapy for intracranial ependimoma in children: the UKCCSG/SIOP Prospective Study. Lancet Oncol 2007;8:696-705.

  20. Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 2001;19:1288-1296.

  21. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, et al.Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 2001;158:1137-1143.

  22. Somit R, Ayala AG, Michal D, Ninett A, Frida S, Boleslaw G, et al. Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet Cytogenet 2000;121:67-72.

  23. Biernat W, Zawrocki A. Molecular alterations in ependymomas. Folia Neuropathol 2007;45:155-163.

  24. Gilbertson RJ, Taylor MD, Poppleton H, Fuller C, Su, X et al. Distinct origins and subtypes of ependymoma revealed by genomic profiling of human and mouse tissues. Twentieth Schweisguth Prize, Vancouver 2005. Société Internationale D´Oncologie Pédiatrique & International Society of Paediatric Oncology.

  25. Carter M, Nicholson J, Ross F, Crolla J Allibone R, Balaji V, et al. Genetic abnormalities detected in ependymomas by comparative genomic hybridization. Br J Cancer 2002;86:929-939.

  26. Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M, et al. Gene expression patterns in ependymomas correlate with tumor location, grade and patient age. Am J Pathol 2003;163:1721-1727.

  27. Kramer DL, Parmiter AH, Rorke LB, Sutton LN, Biegel JA. Molecular cytogenetic studies of pediatric ependymoma. J Neurooncol 1998;37:25-33.

  28. Gilhuis HJ, van der Laak J, Wesseling P, Boerman RH, Beute G, Teepen JL, et al. Inverse correlation between genetic aberrations and malignancy grade in ependymal tumor: A paradox? J Neurooncol 2004;66:111-116.

  29. Debiec-Rychter M, Biernat W, Zakrzewski K, Krul W, Liberski PP. Loss of chromosome 22 and proliferative potential in ependymomas. Folia Neuropathol 2003;41:191-195.

  30. Collins VP. Brain tumors: Classification and genes. J Neurol Psychiatry 2004;75(Suppl II):ii2-ii11.

  31. Biegel JA. Genetics of pediatric central nervous system tumors. J Pediatr Hematol Oncol 1997;19:492-501.

  32. DeVries S, Gray JW, Pinkel D, Waldman FM, Sudar D. Comparative genomic hybridization. Curr Protoc Hum Genet 2001; Chapter 4: Unit 4.6

  33. Paulino AC, Chen-Wen B, Buatti M. Intracranial Ependymomas. Am J Clin Oncol 2002;25:117-122.

  34. Scheil S, Brüderlein S, Eicker M, Herms J, Herold-Mende CH, et al. Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 2001;11:133-143.




2020     |     www.medigraphic.com